Avindra Nath
#48,722
Most Influential Person Now
Canadian physician-scientist
Avindra Nath's AcademicInfluence.com Rankings
Avindra Nathbiology Degrees
Biology
#2745
World Rank
#4319
Historical Rank
Neuroscience
#388
World Rank
#406
Historical Rank
Avindra Nathphilosophy Degrees
Philosophy
#4135
World Rank
#6535
Historical Rank
Logic
#1667
World Rank
#2477
Historical Rank
Download Badge
Biology Philosophy
Why Is Avindra Nath Influential?
(Suggest an Edit or Addition)According to Wikipedia, Avindra "Avi" Nath , is a physician-scientist who specializes in neuroimmunology. Nath is a senior investigator, and intramural clinical director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health in the United States. At NINDS, Nath also leads the Section of Infections of the Nervous System and plans to institute a translational research center. He previously served in several research and administrative positions at the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine.
Avindra Nath's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. (2015) (1321)
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy (2013) (943)
- A full genome search in multiple sclerosis (1996) (709)
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases (2010) (615)
- Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. (1998) (592)
- Disruption of neurogenesis by amyloid β‐peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease (2002) (479)
- Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap (2010) (436)
- Genome-wide Analyses Identify KIF5A as a Novel ALS Gene (2018) (414)
- HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress (1998) (409)
- TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study (1999) (397)
- Transient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes (1999) (377)
- Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands (2000) (375)
- PML diagnostic criteria (2013) (364)
- Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain (2012) (348)
- TNF neutralization in MS (1999) (348)
- Human endogenous retrovirus-K contributes to motor neuron disease (2015) (337)
- Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic (1996) (330)
- Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. (2002) (315)
- Neurological complications of HIV infection (2005) (299)
- Cell death in HIV dementia (2005) (290)
- Microvascular Injury in the Brains of Patients with Covid-19 (2020) (290)
- Human immunodeficiency virus type 1 tat activates non—N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity (1995) (288)
- PML-IRIS in patients with HIV infection (2009) (275)
- Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group. (1984) (265)
- Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta (1991) (261)
- Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine (2000) (259)
- HIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity (2001) (251)
- Perturbation of sphingolipid metabolism and ceramide production in HIV‐dementia (2004) (247)
- Human immunodeficiency virus-associated dementia: An evolving disease (2003) (243)
- Neurobiological aspects of human immunodeficiency virus infection:Neurotoxic mechanisms (1998) (243)
- Molecular Basis for Interactions of HIV and Drugs of Abuse (2002) (241)
- Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis (2011) (235)
- Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy (2019) (229)
- Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. (2000) (226)
- CD4-Independent Infection of Astrocytes by Human Immunodeficiency Virus Type 1: Requirement for the Human Mannose Receptor (2004) (217)
- Mechanisms of the Blood–Brain Barrier Disruption in HIV-1 Infection (2005) (215)
- Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. (2002) (215)
- Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells (1997) (213)
- Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein (2013) (212)
- The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. (1997) (210)
- Progressive multifocal leukoencephalopathy and other forms of JC virus disease (2010) (209)
- Synergistic increases in intracellular Ca2+, and the release of MCP‐1, RANTES, and IL‐6 by astrocytes treated with opiates and HIV‐1 Tat (2005) (206)
- Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia (2000) (204)
- Involvement of Inositol 1,4,5‐Trisphosphate‐Regulated Stores of Intracellular Calcium in Calcium Dysregulation and Neuron Cell Death Caused by HIV‐1 Protein Tat (1999) (200)
- Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum (2000) (197)
- HIV‐Tat protein induces oxidative and inflammatory pathways in brain endothelium (2002) (197)
- Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants (2003) (194)
- HIV-tat induces formation of an LRP–PSD-95– NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytes (2007) (192)
- Neurologic complications of coronavirus infections (2020) (185)
- Neuronal Death Induced by Brain-Derived Human Immunodeficiency Virus Type 1 Envelope Genes Differs between Demented and Nondemented AIDS Patients (1998) (185)
- Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients (2006) (181)
- Human Endogenous Retroviruses in Neurological Diseases (2018) (180)
- Induction of the Chemokines Interleukin-8 and IP-10 by Human Immunodeficiency Virus Type 1 Tat in Astrocytes (2000) (179)
- HIV‐1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells (2003) (177)
- Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. (2000) (177)
- HIV-1 tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain (2003) (177)
- Intracellular Human Immunodeficiency Virus Tat Expression in Astrocytes Promotes Astrocyte Survival but Induces Potent Neurotoxicity at Distant Sites via Axonal Transport* (2003) (172)
- Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro (2001) (167)
- Intraventricular Injection of Human Immunodeficiency Virus Type 1 (HIV-1) Tat Protein Causes Inflammation, Gliosis, Apoptosis, and Ventricular Enlargement (1998) (162)
- Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. (1997) (157)
- Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study (2007) (153)
- CXCL10‐induced cell death in neurons: role of calcium dysregulation (2006) (151)
- Increasing incidence of ischemic stroke in patients with HIV infection (2011) (151)
- Permeability of the blood–brain barrier to HIV-1 Tat (2005) (147)
- Neuronal excitatory properties of human immunodeficiency virus type 1 tat protein (1997) (146)
- HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment (2016) (145)
- A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis (2008) (141)
- Role of Tat Protein in HIV Neuropathogenesis (2009) (141)
- Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes (1996) (138)
- NMDA Receptor Activation by HIV-Tat Protein Is Clade Dependent (2008) (137)
- Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV‐1 tat transgenic mice (2008) (136)
- HIV dementia and the basal ganglia. (1997) (136)
- Synaptic Transport of Human Immunodeficiency Virus-Tat Protein Causes Neurotoxicity and Gliosis in Rat Brain (2003) (136)
- Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia (2019) (135)
- Movement disorders and AIDS (1987) (135)
- ANA Investigates: Neurological Complications of COVID‐19 Vaccines (2021) (133)
- Where does HIV hide? A focus on the central nervous system (2013) (133)
- Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. (2010) (132)
- Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. (2004) (132)
- Immune reconstitution inflammatory syndrome in natalizumab-associated PML (2011) (132)
- A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes (2013) (130)
- Mechanisms of leukocyte trafficking into the CNS. (2000) (126)
- Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. (2006) (124)
- Retroviruses and amyotrophic lateral sclerosis. (2013) (123)
- Human immunodeficiency virus‐1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function (2002) (122)
- Evolution of HIV dementia with HIV infection (2008) (122)
- Parkinsonism with HIV infection (1998) (121)
- Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine (2001) (121)
- Progressive multifocal leukoencephalopathy in transplant recipients (2011) (121)
- Pro‐inflammatory and pro‐oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17β‐estradiol (2001) (121)
- Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells (2005) (120)
- Immunocytochemical and virological characteristics of hiv‐associated inflammatory myopathies: Similarities with seronegative polymyositis (1991) (120)
- Acceleration of HIV dementia with methamphetamine and cocaine (2011) (120)
- Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised (2012) (117)
- Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia (2000) (114)
- HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations (2005) (114)
- Nervous system consequences of COVID-19. (2022) (113)
- Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus (2017) (112)
- Pathobiology of human immunodeficiency virus dementia. (1999) (112)
- Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum (2001) (109)
- Long-Haul COVID (2020) (107)
- HIV and aging (2012) (105)
- Methamphetamine Potentiates HIV-1 Tat Protein-Mediated Activation of Redox-Sensitive Pathways in Discrete Regions of the Brain (2003) (104)
- Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis (2006) (102)
- HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat (2003) (101)
- Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system (2006) (101)
- Estrogen attenuates gp120‐ and tat1–72‐induced oxidative stress and prevents loss of dopamine transporter function (2006) (100)
- Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease (2020) (98)
- Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum (2003) (97)
- Human endogenous retrovirus-K (HML-2): a comprehensive review (2018) (96)
- Eccentric target sign in cerebral toxoplasmosis: Neuropathological correlate to the imaging feature (2010) (96)
- Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat (2003) (95)
- Role of Na+/H+ exchangers, excitatory amino acid receptors and voltage-operated Ca2+ channels in human immunodeficiency virus type 1 gp120-mediated increases in intracellular Ca2+ in human neurons and astrocytes (1999) (94)
- Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML (2012) (93)
- Novel markers of oxidative stress in actively progressive HIV dementia (2004) (91)
- Neurologic Complications of HIV‐1 Infection and Its Treatment in the Era of Antiretroviral Therapy (2012) (88)
- AIDS- and non–AIDS-related PML association with distinct p53 polymorphism (2000) (88)
- Neuroimaging correlates of HIV-associated BBB compromise (2004) (88)
- Cytotoxicity by Matrix Metalloprotease-1 in Organotypic Spinal Cord and Dissociated Neuronal Cultures (2000) (88)
- HIV‐1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology (2009) (87)
- HIV-1 Tat Molecular Diversity and Induction of TNF-α: Implications for HIV-Induced Neurological Disease (1998) (87)
- HIV‐1 neuropathogenesis: glial mechanisms revealed through substance abuse (2007) (86)
- Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. (2008) (85)
- Cerebrovascular changes in the basal ganglia with HIV dementia (2000) (85)
- A Longitudinal Study of Ebola Sequelae in Liberia (2019) (85)
- Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome (2006) (84)
- Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes (1994) (84)
- Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G (2011) (84)
- Is COVID-19 a Perfect Storm for Parkinson’s Disease? (2020) (82)
- Autoantibodies to amyloid β-peptide (Aβ) are increased in Alzheimer’s disease patients and Aβ antibodies can enhance Aβ neurotoxicity (2007) (81)
- The HIV Dementia Scale: Predictive power in mild dementia and HAART (2007) (81)
- Immune reconstitution inflammatory syndrome and the central nervous system. (2011) (80)
- Release of Calcium from Inositol 1,4,5-Trisphosphate Receptor-Regulated Stores by HIV-1 Tat Regulates TNF-α Production in Human Macrophages1 (2000) (80)
- Activation of TRPML1 Clears Intraneuronal Aβ in Preclinical Models of HIV Infection (2014) (80)
- The Tat Protein of HIV-1 Induces Tumor Necrosis Factor-α Production (1997) (79)
- Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation (2022) (79)
- Interleukin-17 in transverse myelitis and multiple sclerosis (2008) (79)
- Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: Protection by diosgenin and l-deprenyl (2006) (79)
- Molecular and cellular mechanisms of neuronal cell death in HIV dementia (2005) (78)
- Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons (2005) (78)
- Neurological complications of immune reconstitution in HIV‐infected populations (2010) (77)
- Neuropathology of HIV/AIDS with an overview of the Indian scene. (2005) (75)
- Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment (2006) (75)
- Minocycline treatment for HIV-associated cognitive impairment (2011) (74)
- Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat (2011) (73)
- Editorial NeuroAIDS review (2011) (73)
- Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases (2017) (72)
- Matrix Metalloproteinase 1 Interacts with Neuronal Integrins and Stimulates Dephosphorylation of Akt* (2004) (72)
- Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy. (2019) (72)
- Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor (2002) (72)
- Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. (1999) (70)
- The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular Ca2+ that require function of an N-methyl-d-aspartate receptor polyamine-sensitive site (2004) (70)
- Molecular targets of opiate drug abuse in neuro AIDS (2005) (70)
- Human immunodeficiency virus type 1 TAT protein induces adhesion molecule expression in astrocytes. (1999) (69)
- Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV‐1 Tat exposure in vitro (2004) (69)
- Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab. (2019) (68)
- Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation (2013) (68)
- Selegiline and oxidative stress in HIV-associated cognitive impairment (2009) (68)
- HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: Changes in dopamine transporter binding and immunoreactivity (2006) (68)
- Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia (2004) (67)
- Oxidative stress and therapeutic approaches in HIV dementia. (2006) (66)
- Human immunodeficiency virus–associated neurocognitive disorder (2010) (66)
- Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells. (2004) (65)
- βA3/A1-crystallin in astroglial cells regulates retinal vascular remodeling during development (2008) (64)
- After the storm (2011) (63)
- Astrocytes as an HIV Reservoir: Mechanism of HIV Infection. (2016) (63)
- Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-d-aspartate receptors at an allosteric zinc-sensitive site (2003) (62)
- HIV-Tat protein and amyloid β peptide form multifibrillar structures that cause neurotoxicity (2017) (61)
- Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. (1997) (60)
- Update on HIV-Associated Neurocognitive Disorders (2013) (60)
- Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease (2021) (59)
- Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism (2018) (59)
- Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)—2′,3′-dideoxycytidine (ddC): Relevance to HIV-dementia (2007) (59)
- Eradication of human immunodeficiency virus from brain reservoirs (2015) (59)
- Methamphetamine-induced TNF-α gene expression and activation of AP-1 in discrete regions of mouse brain (2007) (59)
- Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles. (2004) (58)
- Developments in HIV neuropathogenesis. (2006) (58)
- Movement disorders with cerebral toxoplasmosis and AIDS (1993) (58)
- Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia (2011) (58)
- Eradication of HIV from the brain: reasons for pause. (2011) (57)
- Differential effects of HIV infected macrophages on dorsal root ganglia neurons and axons (2008) (57)
- CNS–Immune Reconstitution Inflammatory Syndrome in the Setting of HIV Infection, Part 1: Overview and Discussion of Progressive Multifocal Leukoencephalopathy–Immune Reconstitution Inflammatory Syndrome and Cryptococcal–Immune Reconstitution Inflammatory Syndrome (2013) (57)
- Granzyme B mediates neurotoxicity through a G‐protein‐coupled receptor (2006) (56)
- Paroxysmal dyskinesias in patients with HIV infection (1999) (56)
- Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study (2020) (56)
- Adult hippocampal neurogenesis: regulation by HIV and drugs of abuse (2007) (55)
- Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders (2013) (55)
- Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: The impact of gender and injection drug use (2005) (55)
- Impairment of adult hippocampal neural progenitor proliferation by methamphetamine: role for nitrotyrosination (2011) (54)
- JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. (2011) (54)
- Three-Dimensional Imaging of HIV-1 Virological Synapses Reveals Membrane Architectures Involved in Virus Transmission (2014) (54)
- Impact of Opiate–HIV-1 Interactions on Neurotoxic Signaling (2006) (54)
- Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients (1998) (53)
- A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy (2006) (53)
- CD8+ T cells target cerebrovasculature in children with cerebral malaria. (2019) (51)
- Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature. (2016) (51)
- Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. (2002) (50)
- Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? (2002) (50)
- Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease (2011) (50)
- Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain (2022) (50)
- Neuropathological correlate of the “concentric target sign” in MRI of HIV‐associated cerebral toxoplasmosis (2013) (49)
- Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID (2022) (49)
- Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women (2011) (49)
- Activated T-Cells Inhibit Neurogenesis by Releasing Granzyme B: Rescue by Kv1.3 Blockers (2010) (48)
- Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis (2012) (48)
- Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases (2011) (48)
- Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation (2013) (48)
- Genetic susceptibility to MS: a second stage analysis in Canadian MS families (2001) (47)
- Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development. (2003) (47)
- Proteomics analysis of human astrocytes expressing the HIV protein Tat. (2005) (46)
- Review: neuronal injury in HIV infection. (1999) (46)
- Hepcidin and iron status among pregnant women in Bangladesh. (2008) (45)
- Chloroquine mediated molecular tuning of astrocytes for enhanced permissiveness to HIV infection. (2008) (45)
- Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial (2019) (45)
- Neurological Complications of Ebola Virus Infection (2016) (45)
- A potential role for β‐ and γ‐crystallins in the vascular remodeling of the eye (2005) (45)
- Proinflammatory synergism of ethanol and HIV-1 Tat protein in brain tissue (2005) (44)
- Tat peptides inhibit neprilysin (2011) (44)
- Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report (2016) (44)
- Primary Headaches in HIV‐Infected Patients (1999) (44)
- Effects of apolipoprotein E on the human immunodeficiency virus protein tat in neuronal cultures and synaptosomes (2004) (43)
- Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid β-peptide (2002) (43)
- Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia. (2007) (43)
- Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India (2006) (42)
- Molecular programming of endothelin‐1 in HIV‐infected brain: role of Tat in up‐regulation of ET‐1 and its inhibition by statins (2007) (42)
- HIV-associated motor neuron disease (2016) (42)
- Viruses and the brain: from inflammation to dementia. (2006) (41)
- Brainstem encephalitis: etiologies, treatment, and predictors of outcome (2013) (41)
- SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. (2003) (41)
- Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism (2006) (41)
- Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism (2005) (41)
- Epidemiological evidence and molecular basis of interactions between HIV and JC virus (2011) (40)
- Neuroinflammation and Not Tauopathy Is a Predominant Pathological Signature of Nodding Syndrome (2019) (40)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- HIV-1 coat protein gp120-induced increases in levels of intrasynaptosomal calcium (1995) (40)
- Inhibition of human endogenous retrovirus-K by antiretroviral drugs (2017) (40)
- Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel (2012) (39)
- Cell-to-cell contact facilitates HIV transmission from lymphocytes to astrocytes via CXCR4 (2015) (39)
- Compounds with species and cell type specific toxicity identified in a 2000 compound drug screen of neural stem cells and rat mixed cortical neurons. (2014) (39)
- Advances toward Curing HIV-1 Infection in Tissue Reservoirs (2019) (39)
- Immune studies in human immunodeficiency virus infection with myasthenia gravis (1990) (39)
- Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA (2016) (39)
- NeuroAIDS in Africa (2010) (39)
- A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission. (1996) (38)
- Neuroprotective therapy for HIV dementia. (2003) (38)
- Nucleoside reverse transcriptase inhibitors and human immunodeficiency virus proteins cause axonal injury in human dorsal root ganglia cultures (2011) (38)
- Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids (2009) (38)
- Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS) (2012) (38)
- Delta opioid agonists attenuate TAT(1-72)-induced oxidative stress in SK-N-SH cells. (2006) (37)
- Arterial ischemic stroke in HIV (2016) (37)
- Methamphetamine activates DNA binding of specific redox‐responsive transcription factors in mouse brain (2002) (36)
- Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase. (2004) (36)
- Human Endogenous Retrovirus-K and TDP-43 Expression Bridges ALS and HIV Neuropathology (2017) (36)
- CNS–Immune Reconstitution Inflammatory Syndrome in the Setting of HIV Infection, Part 2: Discussion of Neuro–Immune Reconstitution Inflammatory Syndrome with and without Other Pathogens (2013) (36)
- Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy (2011) (36)
- AIDS dementia complex with generalized myoclonus (1997) (35)
- Matrix metalloproteinase‐1 activates a pertussis toxin‐sensitive signaling pathway that stimulates the release of matrix metalloproteinase‐9 (2002) (35)
- Characterization of Post–exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (2020) (35)
- Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders (2013) (35)
- Oxidative Stress and the HIV-Infected Brain Proteome (2013) (34)
- Effects of chronic expression of the HIV-induced protein, transactivator of transcription, on circadian activity rhythms in mice, with or without morphine. (2008) (34)
- Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV (2010) (34)
- Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium (2018) (34)
- Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. (2007) (33)
- Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling (2020) (33)
- Cytotoxic effects of exposure to the human immunodeficiency virus type 1 protein Tat in the hippocampus are enhanced by prior ethanol treatment. (2004) (32)
- Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction (2006) (32)
- Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction. (2008) (32)
- Human endogenous retroviruses and the nervous system. (2014) (32)
- Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial (2018) (32)
- Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β (2017) (31)
- Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity (2008) (31)
- STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies (2020) (31)
- Characterization of Human Immunodeficiency Virus (HIV)-Infected Cells in Infiltrates Associated With CNS Opportunistic Infections in Patients With HIV Clade C Infection (2007) (31)
- Activation of Microglia by Borna Disease Virus Infection: In Vitro Study (2006) (31)
- Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes (2003) (30)
- Neurovascular injury with complement activation and inflammation in COVID-19 (2022) (30)
- The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV‐1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load (2006) (29)
- HIV protein, transactivator of transcription, alters circadian rhythms through the light entrainment pathway. (2005) (29)
- Characterization of Inhibitor‐Sensitive and ‐Resistant Adenosine Transporters in Cultured Human Fetal Astrocytes (1996) (29)
- Novel approaches and challenges to treatment of central nervous system viral infections (2013) (29)
- Model organisms contribute to diagnosis and discovery in the undiagnosed diseases network: current state and a future vision (2021) (29)
- CDC Grand Rounds: Chronic Fatigue Syndrome - Advancing Research and Clinical Education. (2016) (29)
- Selective Isolation and Purification of Tat Protein via Affinity Membrane Separation (2008) (29)
- Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment (2014) (29)
- APOE ε4 allele and CSF APOE on Cognition in HIV-Infected Subjects (2011) (29)
- Regulation of stem cell function and neuronal differentiation by HERV-K via mTOR pathway (2020) (29)
- Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of Neuroinflammation (2013) (28)
- Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: Is there a biological explanation? (2011) (28)
- Converging roles for sphingolipids and cell stress in the progression of neuro-AIDS. (2008) (28)
- Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease (2014) (27)
- A potential role for beta- and gamma-crystallins in the vascular remodeling of the eye. (2005) (27)
- Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors. (2011) (27)
- HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant. (2006) (26)
- Fatal immune reconstitution inflammatory syndrome with human immunodeficiency virus infection and Candida meningitis: Case report and review of the literature (2011) (26)
- Global NeuroAIDS Roundtable (2013) (26)
- Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat. (2005) (26)
- Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes (2013) (26)
- NeuroAIDS, Drug Abuse, and Inflammation: Building Collaborative Research Activities (2006) (25)
- Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target? (2014) (25)
- Therapeutic Approaches for Zika Virus Infection of the Nervous System (2017) (25)
- Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins (2007) (25)
- A link between long-term natalizumab dosing in MS and PML (2016) (25)
- Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection (2014) (25)
- Challenges to the diagnosis and management of HIV dementia. (2006) (24)
- New insights into immune reconstitution inflammatory syndrome of the central nervous system (2014) (24)
- Neurologic Consequences of the Immune Reconstitution Inflammatory Syndrome (IRIS) (2010) (24)
- Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases (2018) (24)
- Silencing of immune activation with methotrexate in patients with COVID-19 (2020) (23)
- Molecular mechanisms in the dramatic enhancement of HIV‐1 Tat transduction by cationic liposomes (2012) (23)
- Fatal encephalopathy with wild‐type JC virus and ruxolitinib therapy (2019) (23)
- Neurological issues during COVID-19: An overview (2020) (23)
- CNS immune reconstitution inflammatory syndrome. (2018) (22)
- Progression of progressive multifocal leukoencephalopathy despite treatment with β-interferon (2006) (22)
- HIV and Alzheimer’s disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein (2019) (22)
- 14-3-3 Protein in CSF: An Early Predictor of SIV CNS Disease (2005) (21)
- Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability (2003) (21)
- Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry (2014) (21)
- Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users (2011) (20)
- Productive HIV infection in astrocytes can be established via a nonclassical mechanism. (2020) (20)
- Chronic Dengue Virus Panencephalitis in a Patient with Progressive Dementia with Extrapyramidal Features (2019) (20)
- Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. (1991) (20)
- Probing the mechanism of inhibition of amyloid-β(1–42)–induced neurotoxicity by the chaperonin GroEL (2018) (20)
- Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors (2020) (20)
- The Association Between Post-traumatic Stress Disorder and Markers of Inflammation and Immune Activation in HIV-Infected Individuals With Controlled Viremia. (2016) (19)
- Antibody response to rubella virus structural proteins in multiple sclerosis (1990) (19)
- Immune modulation by estrogens (2006) (18)
- An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (2020) (18)
- Future Directions of Training Physician-Scientists: Reimagining and Remeasuring the Workforce. (2019) (18)
- Survivors of Ebola Virus Disease Have Persistent Neurological Deficits (S53.003) (2016) (18)
- Human immunodeficiency virus type 1 Tat-mediated cytotoxicity of human brain microvascular endothelial cells (2003) (17)
- Robust two-dimensional separation of intact proteins for bottom-up tandem mass spectrometry of the human CSF proteome. (2012) (16)
- Complications of Immunosuppressive/Immunomodulatory Therapy in Neurological Diseases (2012) (16)
- Neuroinfectious diseases: a crisis in neurology and a call for action. (2015) (16)
- Impaired toll-like receptor 8 signaling in multiple sclerosis (2013) (16)
- Global and regional brain hypometabolism on FDG-PET in treated HIV-infected individuals (2018) (16)
- Case 11: a young woman with ring-enhancing brain lesions. (2006) (15)
- Serial immune evaluation of cyclosporine- and placebo-treated multiple sclerosis patients (1988) (15)
- Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and Alzheimer’s disease (2019) (15)
- Neurologic Complications of Smallpox and Monkeypox: A Review. (2022) (15)
- Remedies for HIV-associated peripheral neuropathy (2000) (15)
- HIV-associated neurocognitive disorders : recent advances in pathogenesis , biomarkers , and treatment (2019) (15)
- Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS (2022) (14)
- Direct induction of human neural stem cells from peripheral blood hematopoietic progenitor cells. (2015) (14)
- Cerebrospinal Fluid Examination in Survivors of Ebola Virus Disease (2017) (14)
- Productive HIV infection in astrocytes can be established via a non-classical mechanism. (2020) (14)
- An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients (2020) (14)
- Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients treated with Pulse - Taper Corticosteroids for Post-infectious Inflammatory Syndrome. (2020) (14)
- Estradiol negatively regulates HIV-LTR promoter activity in glial cells. (2006) (14)
- The Pathogenesis of Nodding Syndrome. (2020) (14)
- Robust, atlas-free, automatic segmentation of brain MRI in health and disease (2019) (13)
- COVID-19-Induced Anosmia and Ageusia Are Associated With Younger Age and Lower Blood Eosinophil Counts (2021) (13)
- Tat and amyloid: multiple interactions. (2005) (13)
- Neurologic Complications of Human Immunodeficiency Virus Infection (2015) (13)
- Protection of human cerebral neurons from neurodegenerative insults by gene delivery of soluble tumor necrosis factor p75 receptor (2005) (13)
- Gene transfer of baculoviral p35 by adenoviral vector protects human cerebral neurons from apoptosis. (2004) (13)
- Ocular motor dysfunction in HIV-1-infected subjects (1996) (13)
- Neurotrophin Strategies for Neuroprotection: Are They Sufficient? (2014) (12)
- Clinical sites of the Undiagnosed Diseases Network: Unique contributions to genomic medicine and science (2020) (12)
- Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases (2021) (12)
- Recognition based separation of HIV-Tat protein using avidin–biotin interaction in modified microfiltration membranes (2006) (12)
- Clinicopathology conference: 41‐year‐old woman with chronic relapsing meningitis (2019) (12)
- Response of human macrophages to gamma radiation is mediated via expression of endogenous retroviruses (2021) (12)
- Aphasia As a Complication Of CD19-Targeted Chimeric Antigen Receptor Immunotherapy (S52.006) (2014) (12)
- Cerebral toxoplasmosis (2003) (12)
- Identification of Nitrated Immunoglobulin Variable Regions in the HIV-Infected Human Brain: Implications in HIV Infection and Immune Response (2014) (12)
- Activated T cells induce proliferation of oligodendrocyte progenitor cells via release of vascular endothelial cell growth factor‐A (2018) (12)
- Neurological manifestations of Erdheim–Chester Disease (2020) (12)
- Soluble and Cell-Associated Insulin Receptor Dysfunction Correlates with Severity of HAND in HIV-Infected Women (2012) (12)
- Protocol for Detection of HIV-Tat Protein in Cerebrospinal Fluid by a Sandwich Enzyme-Linked Immunosorbent Assay. (2016) (11)
- Soluble insulin receptor as a source of insulin resistance and cognitive impairment in HIV-seropositive women (2015) (11)
- BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study (2021) (11)
- The absence of JC virus antigens in Indian children with medulloblastomas. (2009) (11)
- Parasitic Infections of the Nervous System (2019) (11)
- Neurological complications of COVID-19: from bridesmaid to bride. (2020) (11)
- SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression (2021) (11)
- Neurological syndromes driven by postinfectious processes or unrecognized persistent infections (2018) (11)
- HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection (2019) (10)
- CNS infections in 2015: emerging catastrophic infections and new insights into neuroimmunological host damage (2016) (10)
- Detection of auto-antibodies to leiomodin-1 in patients with nodding syndrome (2014) (10)
- Ocular motor dysfunction in HIV-1-infected subjects: a quantitative oculographic analysis (1996) (10)
- Diagnosis of cerebral toxoplasmosis (2011) (10)
- Neurologic Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection (2021) (10)
- Modulation of human immunodeficiency virus infection by anticonvulsant drugs (2011) (10)
- Utility of molecular and serodiagnostic tools in cerebral toxoplasmosis with and without tuberculous meningitis in AIDS patients: A study from South India (2010) (10)
- Gene chromosomal organization and expression in cultured human neurons exposed to cocaine and HIV-1 proteins gp120 and tat: drug abuse and NeuroAIDS. (2006) (10)
- Metastatic renal cell carcinoma simulating glumus jugulare tumor (1987) (9)
- Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder. (2020) (9)
- HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil (2021) (9)
- COVID-19 and Vaccination in the Setting of Neurologic Disease (2021) (9)
- Neuroinflammatory Changes in Relation to Cerebrospinal Fluid Viral Load in Simian Immunodeficiency Virus Encephalitis (2019) (8)
- Association of White Matter Hyperintensities With HIV Status and Vascular Risk Factors (2021) (8)
- Diadenosine pentaphosphate increases levels of intracellular calcium in astrocytes by a mechanism involving release from caffeine/ryanodine‐ and IP3‐sensitive stores (2000) (8)
- Evaluation and Immunomodulatory Treatment at the NIH of Children with Nodding Syndrome from Northern Uganda (S37.005) (2015) (8)
- Mechanisms of viral persistence in the brain and therapeutic approaches (2021) (8)
- HIV-associated Dementia (2005) (8)
- Primary cerebellar T-cell lymphoma with acquired immunodeficiency syndrome. (1997) (8)
- COVID-19 and Vaccination in the Setting of Neurologic Disease An Emerging Issue in Neurology (2021) (8)
- Bioinformatics models in drug abuse and Neuro-AIDS: Using and developing databases (2006) (7)
- Technical considerations in detection of HERV-K in amyotrophic lateral sclerosis: selection of controls and the perils of qPCR (2019) (7)
- Association of Herpes Viral Infections, Antiherpetic Therapy, and Dementia: Real or Alternative Fact? (2018) (7)
- Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain (2020) (7)
- Neurotoxicities associated with checkpoint inhibitors: Two case reports and a review of the literature (2019) (7)
- HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors (2013) (7)
- First international workshop on human endogenous retroviruses and diseases, HERVs & disease 2015 (2015) (7)
- Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders (2017) (7)
- Mass spectrometric phosphoproteome analysis of HIV‐infected brain reveals novel phosphorylation sites and differential phosphorylation patterns (2016) (7)
- The role of human endogenous retroviruses in gliomas: from etiological perspectives and therapeutic implications. (2021) (7)
- Lipid nanoparticles with accessible nickel as a vaccine delivery system for single and multiple his-tagged HIV antigens (2009) (7)
- HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19 (2021) (7)
- Central nervous system-immune reconstitution inflammatory syndrome in resource-limited settings: current burden and future needs. (2012) (7)
- Potential Mechanism for HIV-Associated Depression: Upregulation of Serotonin Transporters in SIV-Infected Macaques Detected by 11C-DASB PET (2019) (6)
- Different roles of Sp family members in HIV-1 Tat-mediated manganese superoxide dismutase suppression in hepatocellular carcinoma cells. (2005) (6)
- The Virtues of Unique Ribonucleotide Reductase Inhibitors Didox and Trimidox for Retrovirus Therapy (2007) (6)
- Release of Soluble Insulin Receptor From Neurons by Cerebrospinal Fluid From Patients With Neurocognitive Dysfunction and HIV Infection (2019) (6)
- Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis (2022) (6)
- Effect of cyclosporine on rubella virus-specific immune responses in chronic progressive multiple sclerosis (1989) (6)
- Management of Brain Abscess (2007) (6)
- Neuroprotective and Antiretroviral Effects of the Immunophilin ligand GPI 1046 (2007) (6)
- Characterization of Nitrotyrosine-Modified Proteins in Cerebrospinal Fluid (2010) (6)
- Neuropathic symptoms with SARS-CoV-2 vaccination (2022) (5)
- CD4-Independent Infection of Astrocytes by Human Immunodeficiency Virus Type 1: Requirement for the Human Mannose Receptor (2004) (5)
- Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations (2021) (5)
- Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy. (2019) (5)
- Closing the Loop between Nodding Syndrome and Onchocerca Infection. (2017) (5)
- Human immunodeficiency virus infections (1993) (5)
- COVID-19 and Vaccination in the Setting of Neurologic Disease An Emerging Issue in Neurology COVID-19 Vaccines Currently Approved for Use in the United States and Vaccination in the Setting of Disease: An Emerging Issue in (5)
- regulatory protein tat in CNS tissues (2000) (5)
- Acute flaccid myelitis and enterovirus D68 (2017) (5)
- HIV meningitis and dementia (2003) (5)
- Potential complications of monkeypox (2022) (4)
- Translational Research in NeuroAIDS: A Neuroimmune Pharmacology-Related Course (2011) (4)
- Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: "Second International Workshop on Human Endogenous Retroviruses and Disease", Washington DC, March 13th and 14th 2017. (2017) (4)
- Clinical Progressive Multifocal Leukoencephalopathy: Diagnosis and Treatment (2002) (4)
- Metastatic renal cell carcinoma simulating glomus jugulare tumor. (1988) (4)
- Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic (2022) (4)
- John Cunningham Virus Antibody and Viremia as Predictors of Progressive Multifocal Leukoencephalopathy in Human Immunodeficiency Virus-1–Infected Individuals (2011) (4)
- 420 – Meningitis: Bacterial, Viral, and Other (2011) (4)
- Infections of the Central Nervous System (2010) (4)
- One is the loneliest number: genotypic matchmaking using the electronic health record (2021) (4)
- Grand Challenges in Neuroinfectious Diseases (2017) (4)
- Correction to: Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium (2019) (4)
- Mechanisms of leukocyte traf ® cking into the CNS (2000) (4)
- 421 – Brain Abscess and Parameningeal Infections (2011) (4)
- In-vivo MRI Reveals Changes to Intracerebral Vasculature Caliber in HIV Infection (2019) (4)
- Letter to Editor (2018) (3)
- Erratum: De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia (The American Journal of Human Genetics (2019) 105(2) (413–424), (S0002929719302393), (10.1016/j.ajhg.2019.06.014)) (2019) (3)
- Physician-scientists in neurology (2018) (3)
- Antibody Response to HML‐2 May Be Protective in Amyotrophic Lateral Sclerosis (2022) (3)
- Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patients (2022) (3)
- Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users (2011) (3)
- Prolonged Posttreatment Virologic Control and Complete Seroreversion After Advanced Human Immunodeficiency Virus-1 Infection. (2020) (3)
- Central Nervous System Infections in Childhood. (2015) (3)
- Letter to Editor (2018) (3)
- Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis (2022) (3)
- Unraveling the Mysteries of Acute Flaccid Myelitis: Scientific Opportunities and Priorities for Future Research. (2020) (3)
- Strengthened through Diversity: A Blueprint for Organizational Change (2021) (3)
- Neurological manifestations of coronavirus infections (2020) (3)
- Methamphetamine and HIV Infection, Role in Neurocognitive Dysfunction (2009) (2)
- Accounts from Liberia: Reports of Neurological Manifestations During the Acute Phase of Ebola Virus Disease (P1.283) (2016) (2)
- Neuropsychological Consequences of HIV and Drug Ause (2006) (2)
- Interactions of the human immunodeficiency virus with astrocytes (1996) (2)
- Effect of HIV and Interpersonal Trauma on Cortical Thickness, Cognition, and Daily Functioning. (2020) (2)
- The neuroinflammation collection: a vision for expanding neuro-immune crosstalk in Brain (2021) (2)
- Genomic analysis, immunomodulation and deep phenotyping of patients with nodding syndrome. (2022) (2)
- The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard ‘Dick’ T. Johnson (2017) (2)
- Thinning of Retinal Nerve Fiber Layer Is Associated with Neurocognitive Impairment in HIV Infected Women (P01.263) (2012) (2)
- Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation. (2021) (2)
- Immunoregulation in MS patients treated with cyclosporine (1987) (2)
- Loss of sense of smells associated with sour taste is a possible diagnostic marker for COVID-19 (2021) (2)
- Apoptosis in HIV disease pathogenesis (2001) (1)
- Risk Factors Associated With COVID-19 Related Anosmia And Ageusia (2021) (1)
- Activation of HERV-K and response to antiretroviral therapy in patients with HIV infection and motor neuron disease (I4-1A) (2015) (1)
- Author and Subject Index (1998) (1)
- Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology (2023) (1)
- Herpes Viruses, Alzheimer’s Disease, and Related Dementias: Unifying or Confusing Hypothesis? (2018) (1)
- New Insights into HIV Neuropathogenesis (2009) (1)
- Infection of Human Fetal Astrocytes with HIV (1995) (1)
- 718. PTD-Fusion Peptide as a Delivery Vehicle for siRNA To Target HIV Reservoirs (2006) (1)
- Molecular Study of HIV-Tat Aggregation (2016) (1)
- Clinical Profile and Outcomes of COVID-19–Associated Transverse Myelitis (2022) (1)
- Selective Isolation and Purification of Genetically Modified Tat Protein by Stacked Affinity Membrane System (2006) (1)
- Erratum to: Characterization of Nitrotyrosine-Modified Proteins in Cerebrospinal Fluid (2010) (1)
- CHAPTER 30 – Approach to the Patient with a Cerebrospinal Fluid Pleocytosis (2009) (1)
- Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (2021) (1)
- Progressive multifocal leukoencephalopathy lesion and brain parenchymal segmentation from MRI using serial deep convolutional neural networks (2020) (1)
- CNS Complications in Immunodeficiency Syndromes Due to Mutations in Transcription Factors STAT-1 and GATA-2 (S57.003) (2012) (1)
- Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption (2022) (1)
- Changing pattern and pathophysiology of cognitive dysfunction with HIV infection in the era of antiretroviral therapy (2011) (1)
- The Practice of Experimental Neurotherapeutics in Neuromuscular Disease (2022) (1)
- Impaired toll-like receptor 8 signaling in multiple sclerosis (2013) (1)
- Reducing Events of Noncompliance in Neurology Human Subjects Research: the Effect of Human Subjects Research Protection Training and Site Initiation Visits (2021) (1)
- Influence of Research Continuity on Physician-Scientists’ Career Success (2021) (1)
- LETTERS TO THE EDITOR (1959) (1)
- Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations (2021) (1)
- Cerebellar syndrome in a man treated with natalizumab (2019) (1)
- Anti-idiotypic antibodies to rubella virus (2005) (1)
- Central nervous system infections (2015) (1)
- Neuropathogenesis of viral infections (2020) (1)
- PML: underdiagnosed in MS patients on natalizumab – Authors' reply (2010) (1)
- Longitudinal cohort study of neurological sequelae in ebola virus disease survivors in liberia (2017) (1)
- Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS) (2012) (1)
- Retroviral Elements in Human Evolution and Neural Development (2021) (1)
- PML-IRIS in multiple sclerosis patients treated with natalizumab (2010) (1)
- Association of Herpes Viral Infections, Antiherpetic Therapy, and Dementia: Real or Alternative Fact? (2018) (0)
- Neurological Practice: An Indian Perspective (2006) (0)
- Differential regulation of striatal neuron cell death through HIV-1 Tat- and gp120-induced activation of p38 and c-jun-N-terminal kinases (2003) (0)
- Eradication of human immunodeficiency virus from brain reservoirs (2014) (0)
- Production in Human Macrophages α Stores by HIV-1 Tat Regulates TNF-1 , 4 , 5-Trisphosphate Receptor-Regulated Release of Calcium from Inositol (2000) (0)
- Development of a Functional Scale for Progressive Multifocal Leukoencephalopathy: The NIH PML Scale (S10.005) (2014) (0)
- Neurotrophin Strategies for Neuroprotection: Are They Sufficient? (2014) (0)
- Biochemical Evidence Of Neuronal Injury In HIV Patients With Normal Neurocognitive Function Defines Pre-Symptomatic Stage (P4.309) (2014) (0)
- Nuclear factor kappa B transcription profiling of genes protect against nitric oxide-induced neuronal apoptosis. (2004) (0)
- Free posters B (2011) (0)
- HIV and aging (2012) (0)
- Establishment of a Registry To Identify Cases of PML Using Uniform Diagnostic Criteria (S08.002) (2012) (0)
- Immune reconstitution inflammatory syndrome occurring in progressive multifocal leukoencephalopathy with natalizumab for multiple sclerosis (2010) (0)
- Detection of the human immunode ® ciency virus (2000) (0)
- Editorial (2016) (0)
- STEM-07. DEFINING THE ROLE OF HUMAN ENDOGENOUS RETROVIRUS-K (HML-2) IN THE GLIOBLASTOMA STEM-CELL NICHE (2022) (0)
- Neurological infections: risks of globalisation and new drugs (2012) (0)
- 367. Use of a Brief Task-Based Measure to Assess the Functional Consequences of Cognitive Impairment in HIV (2019) (0)
- Clinical Infectious Disease: Rabies (2015) (0)
- Meet Our Co-Editor: (2016) (0)
- Book Review: The Neurology of AIDS (1998) (0)
- Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection (2014) (0)
- Reply (2007) (0)
- 17th International Confernce on Human Retroviruses: HTLV and Related Viruses (2015) (0)
- Imaging of the serotonin transporter in depressed HIV-positive patients using [11C]DASB-PET (2008) (0)
- Obituary: Richard T. Johnson, M.D. (2016) (0)
- Another 'BEE'? - Brain-Eye-Ear (BEE) Disease Secondary to HbSC Disease Masquerading as Multiple Sclerosis. (2021) (0)
- Major advances in neuroinfectious diseases in the past two decades (2022) (0)
- Obituary: Richard T. Johnson, M.D. (2016) (0)
- Urinary excretion of aminoacids in mentally retarded children. A study of 150 cases by circular paper chromatography. (1970) (0)
- Urinary excretion of carcinogenic tryptophane metabolites in cancer of bladder. (1969) (0)
- Neurological Complications of Ebola Virus Infection (2016) (0)
- Herpes Virus Infections of the Brain Complicating Allogeneic Hematopoietic Stem Cell Transplantation (SCT) (S57.001) (2012) (0)
- VarSight: prioritizing clinically reported variants with binary classification algorithms (2019) (0)
- Human Brain theVirus-Induced Demyelinating Disease of Leukoencephalopathy , the JC Pathogenesis of Progressive Multifocal (2012) (0)
- Delayed hospital presentation and delayed acyclovir administration- the major causes of morbidity and mortality in Herpes simplex encephalitis (2010) (0)
- 021 Fludarabine-induced subacute, often fatal leukoencephalopathy: a case series (2019) (0)
- SI for NeuroAIDS: CNS function and dysfunction when HIV is a chronic disease (2023) (0)
- HIV-Tat Protein Enhances Amyloid Beta Peptide Aggregation (2014) (0)
- Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation (2013) (0)
- Insufficient Tat Production Leads to Latent HIV Infection in Astrocytes (2005) (0)
- 401 – Neurologic Complications of Human Immunodeficiency Virus Infection (2012) (0)
- Glioblastoma multiforme in patients with human immunodeficiency virus: an integrated review and analysis (2022) (0)
- Therapeutic Approaches for Zika Virus Infection of the Nervous System (2017) (0)
- HIV and the Nervous System (2020) (0)
- 378 – Cytomegalovirus, Epstein-Barr Virus, and Slow Virus Infections of the Central Nervous System (2012) (0)
- Postmortem MRI in Progressive Multifocal Leukoencephalopathy (P02.272) (2012) (0)
- A Pilot Study of Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy with Ex Vivo Generated Polyomavirus-Specific T-Cells (2018) (0)
- Amyotrophic lateral sclerosis: translating genetic discoveries into therapies. (2023) (0)
- Experimental Neurotherapeutics: Surfing the Tidal Wave of New Opportunities (2022) (0)
- Human immunodeficiency virus type l (H1V-1) gp120-induced increases in reactive oxygen species in human U937 cells (1996) (0)
- infection Increasing incidence of ischemic stroke in patients with HIV January (2011) (0)
- Neurologic Complications With Vaccines: What We Know, What We Don't, and What We Should Do (2023) (0)
- Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease (2014) (0)
- First international workshop on human endogenous retroviruses and diseases, HERVs & disease 2015 (2015) (0)
- Abnormal Brain Pathology in Virologically Controlled HIV-Infected Individuals (S38.003) (2013) (0)
- A monoclonal antibody against HIV Tat attenuates neurotoxicity via glutamate receptors (2006) (0)
- Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases (2015) (0)
- Fluconazole Is Neuroprotective via Interactions with the IGF-1 Receptor (2022) (0)
- Direct Conversion to Neurons from Adult Human Fibroblasts and Hematopoietic Stem Cells In Vitro (IN8-1.003) (2012) (0)
- Neurocognitive Dysfunction With Neuronal Injury in People With HIV on Long-Duration Antiretroviral Therapy. (2023) (0)
- Movement Disorders in Neurologic and Systemic Disease: Movement disorders in HIV- and AIDS-related central nervous system infections (2012) (0)
- Pathophysiology of neurological manifestations of HIV infection (2011) (0)
- Erratum to: Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection (2015) (0)
- TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A (2022) (0)
- Smallpox complications (2022) (0)
- 135 Dramatic enhancement of uptake and trafficking of HIV-1 Tat protein via modulation of endocytosis pathways (2009) (0)
- Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders (2013) (0)
- Free posters B (2002) (0)
- Activated T cells induce oligodendrocyte progenitor cells proliferation by releasing VEGF-A (2014) (0)
- Substance Use Disorders and Neuro-AIDS in the HAART Era (2009) (0)
- HIV Infection and the PNS (2010) (0)
- Activation of NMDA receptor subtypes NR 1 / NR 2 B by macrophage secretory products : a possible neurotoxic pathway for HIV-1 dementia (2005) (0)
- Monocytes UpRegulates CCR 5 Expression on Human the Human Blood-Brain Barrier and Monocyte Transmigration Across a Model of Chemoattractant Protein-1-Mediated HIV-1 Tat Induces Monocyte (1999) (0)
- Neuroinflammatory Disease Responsive to MEK-Inhibitor (2022) (0)
- Neurotoxic HIV-Tat Autocleaves and Forms Novel Amyloid-Like Fibrillar Structures (2019) (0)
- Reply: The spectrum of complement pathway activation is integral to the pathogenesis of severe COVID-19. (2022) (0)
- Oxidative Stress and the HIV-Infected Brain Proteome (2013) (0)
- Sociodemographic and Clinical Factors Associated with Clinical Outcome in Neuroinflammatory Conditions: An Eight-Year Multicenter Retrospective Cohort Study (2022) (0)
- Contributors (2012) (0)
- Immunophenotyping of cerebrospinal fluid cells in virus-associated neurologic diseases (2015) (0)
- (PO-081) Childhood Trauma Modifies the Impact of Brain Volume on Cognitive and Daily Functioning in Virally-suppressed People with HIV (2022) (0)
- Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection (2023) (0)
- Human immunodeficiency virus-1 Tat protein upregulates IL-6 and IL-8 expression in human breast cancer cells (2004) (0)
- Receptor Requirement for the Human Mannose Human Immunodeficiency Virus Type 1 : CD 4-Independent Infection of Astrocytes by (2004) (0)
- The HIV protein Tat-induced induction of in ammatory responses in the brain tissue (2005) (0)
- A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes (2013) (0)
- Colloquium C10: Opioid Peptides: Normal & Pathologic Signaling Mechanisms in Neurons & Glia (2003) (0)
- Endogenous retroviruses in amyotrophic lateral sclerosis (2016) (0)
- 2-04-12 Progressive multifocal leukoencephalopathy: incidence and survival (1997) (0)
- Dedication to Dr. Richard T. Johnson (2016) (0)
- Inhibition of human endogenous retrovirus-K by antiretroviral drugs (2017) (0)
- Gp120 induced neurotoxicity – The influence of the chemokine receptor tropism (2006) (0)
- 47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis (2020) (0)
- Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders (2013) (0)
- Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium (2018) (0)
- Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β (2017) (0)
- Dedication to Dr. Richard T. Johnson (2016) (0)
- Retinal Thinning in People With Well-Controlled HIV Infection (2022) (0)
- Technical considerations in detection of HERV-K in amyotrophic lateral sclerosis: selection of controls and the perils of qPCR (2019) (0)
- Retrotransposon insertions associated with risk of neurologic and psychiatric diseases (2022) (0)
- Reducing Events of Noncompliance in Neurology Human Subjects Research: the Effect of Human Subjects Research Protection Training and Site Initiation Visits (2021) (0)
- Subcortical Gray Matter Loss and Ventricular Enlargement Define Specific HIV Biotypes (S25.008) (2023) (0)
- STROBE-Metagenomics: A STROBE/STROME-ID Extension Statement to Guide the Reporting of Studies Applying Metagenomics (2020) (0)
- Contents: Proteomics 2'16. (2016) (0)
- Paris , FR ) P . Cinque ( Milan , IT ) P 113 Altered gene expression in HTLV-I-infected CD 4 + T cells may promote deregulated CD 8 + T cell responses associated with HTLV-I-mediated disease pathogenesis (0)
- Author response. (2013) (0)
- Infectious Diseases of the Nervous System (2010) (0)
- RABIES (1969) (0)
- Prospective Evaluation of an Abbreviated Test Battery to Screen for Neurocognitive Impairment in HIV-Positive Military Members (2021) (0)
- Joint Symposium The 2nd International Symposium: Polyomaviruses and Human Diseases and 4th International Symposium for Zoonosis Control “Emerging Virus Infections” (2011) (0)
- Dendritic pathology and neuronal injury induced by Tat and opiates in a transgenic model of HIV‐1 encephalitis (2008) (0)
- Multiple Sclerosis Therapeutics: Neuroprotection in multiple sclerosis (2011) (0)
- Herpes Viruses, Alzheimer’s Disease, and Related Dementias: Unifying or Confusing Hypothesis? (2019) (0)
- A Possible Function of ß– and –Crystallins in Vascular Remodeling (2005) (0)
- Robert J. Cotter (1943–2012): From Mass Spectrometer Development to the Exploration of Life (2013) (0)
- ANA Webinars: Clinical and basic research resilience during COVID‐19 (2020) (0)
- Lead Authors and Contributors (2010) (0)
- 379 Human Endogenous Retrovirus-K (HML-2) Contributes to a Unique Stem-Cell Niche in Glioblastoma (2023) (0)
- Correction to: Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium (2019) (0)
- Detection of SARS-CoV-2 Nucleocapsid and Microvascular Disease in the Brain (2022) (0)
- Role of an Endogenous Retrovirus in ALS Pathophysiology and Effect of Anti-Retrovirals In Vitro (P5.203) (2016) (0)
- Novel Method Measuring Intracranial Vessel Caliber Reveals Arterial Remodeling In HIV (P6.072) (2016) (0)
- New treatment options for Zika virus infection (2021) (0)
- HIV-TAT 32-62 Protein Fragment Forms Fibrillar Structures (2018) (0)
- Infections of the Nervous System (2015) (0)
- Detection Of Increased Transcripts Of Human Endogenous Retrovirus In Plasma Of Patients With Frontotemporal Dementia Associated Amyotrophic Lateral Sclerosis (S40.004) (2014) (0)
- HIV-Tat Protein-Amyloid Beta Complex: From Molecular Interaction to Increased Neurotoxicity (2015) (0)
- In memoriam: Richard T. Johnson, 1931–2015 (2015) (0)
- Soluble insulin receptor as a source of insulin resistance and cognitive impairment in HIV-seropositive women (2015) (0)
- Erratum to: Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection (2015) (0)
- Global NeuroAIDS Roundtable (2013) (0)
- HIV and Alzheimer’s disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein (2019) (0)
- Immunomodulatory Therapy for Multiple Sclerosis (2017) (0)
- Compositions et méthodes d'inhibition du virus jc (jcv) (2014) (0)
- Morphological Study of Penile Chancroid Lesions in Human Immunodeficiency Virus(HIV) (1996) (0)
- Defining PML Spectrum Disease (P5.101) (2018) (0)
- Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial (2017) (0)
- HIV-1 and Tat Neuropathogenesis and Therapeutic Targets (2011) (0)
- Novel Role of βA3/A1-Crystallin in Astrocytes of Developing Retina (2008) (0)
- NFBP , a novel human protein from glial cells that interacts the NF-kappaB subunits to modulate HIV-1 LTR (2005) (0)
- Quantification of HLA Allele and Haplotype Frequencies in ALS and ALS-FTD (P8-8.005) (2023) (0)
- Imbalanced immune response and dysregulation of neural functions underline fatal opportunistic encephalitis caused by astrovirus (2022) (0)
- PPAR-Gamma Receptor mediated severe thyroid toxicity in Mice (2009) (0)
- Compositions et méthodes de neuroprotection (2007) (0)
- 1H-MRS, MRI, and CSF predictors of HIV dementia Preliminary results from ongoing longitudinal studies (2002) (0)
- Protease-activated Receptor-1 (PAR-1) and Interleukin-1Beta Act Synergistically in Granzyme b Mediated Neurotoxicity (P1.159) (2014) (0)
- Gonadal Hormone Dysfunction Modulates CSF Oxidative Stress Markers in HIV-Seropositive Women with Cognitive Impairment (S37.002) (2012) (0)
- Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment (2014) (0)
- Movement disorders with AIDS encephalopathy (1987) (0)
- Rubella (2020) (0)
- Cigarette smoking and cognitive function in human immunodeficiency virus seropositive women Short running title : Smoking and cognition in women with HIV (2007) (0)
- Discrepant fi ndings in immune responses to JC virus in patients receiving natalizumab (2010) (0)
- Neuromuscular POLIOMYELITIS (2008) (0)
- CXCR4-usage HIV-1 strains isolated from blood and cerebrospinal fluid in subjects on suppressive antiretroviral therapy (2019) (0)
- Robert J. Cotter (1943–2012): From Mass Spectrometer Development to the Exploration of Life (2013) (0)
- Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry (2014) (0)
This paper list is powered by the following services:
Other Resources About Avindra Nath
What Schools Are Affiliated With Avindra Nath?
Avindra Nath is affiliated with the following schools:
